Opioid is a type of narcotic pain medication, which is used
to treat moderate to severe pain, such as, anesthesia, cough suppression,
diarrhea suppression, surgical pain, injury or trauma, cancer pain and pain
arising from disease. The global Opioids
Market is estimated to account for US$ 51,005.8 Mn in terms of value by the
end of 2027.
Global Opioids Market: Drivers
High efficacy of synthetic opioids such as methadone and
fentanyl is expected to boost growth of the global opioids market. These
synthetically manufactured opioids are used to suppress the chances of getting
addicted to natural opioids and resistant to natural opioids.
Global Opioids Market: Opportunities
Increasing R&D in synthesis of hybrids targeting opioid
and neurokinin receptors is expected to offer lucrative growth opportunities
for market players. For instance, in December 2019, researchers from Medical
University of Lodz reported the synthesis, structure–activity relationship, and
pharmacological characterization of a series of hybrids combining opioid
pharmacophores with either substance P (SP) fragments or neurokinin receptor
(NK1) antagonist fragments in order to comprehend the role of the neurokinin
system in opioid-induced antinociception.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1017
Global Opioids Market: Restraints
However, increasing cases of
counterfeit opioids is expected to hamper growth of the global opioids market.
For instance, in June 2019, Drug Enforcement Administration warned regarding
sell of counterfeit fentanyl pills and other synthetic opioids.
Key Takeaways:
The Morphine segment in the
global opioids market was valued at US$ 13,697.6 Mn in 2018 and is expected to
reach US$ 17,766.2 Mn by 2027 at a CAGR of 2.9% during the forecast period. The
growth of the segment is attributed to increasing demand for treatment of acute
and chronic pain during the forecast period. The Analgesia segment held
dominant position in the global opioids market in 2018, accounting for 67.3%
share in terms of volume, followed by cough suppression and diarrhoea
suppression, respectively. The growth of the segment is attributed to
increasing research and development of new drug.
Market Trends
Key players in the market are
focused on product approval and launch to expand their product portfolio. For
instance, in June 2018, AcelRx Pharmaceuticals, Inc. received the European
Commission (EC) approval for DZUVEO for the management of acute moderate to
severe pain in adults in medically monitored settings. The market is witnessing
increasing M&A activities. For instance, Grünenthal acquired the US-based
pharmaceutical company Averitas Pharma in order to expand its presence in the
U.S.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/opioid-drugs-market-1017
Regulations
The European Society for Medical
Oncology (ESMO) and the European Association for Palliative Care (EAPC)
regulates the commercial use of opioids in cancer pain management across Europe
European Union conducts Access to
Opioids Medication in Europe (ATOME) program, which ensures the availability of
opioids across 12 European countries
The U.K.’s Department of Health
published "Drug Misuse and Dependence – Guidelines on Clinical
Management" (DOH, 1999), which regulates the prescription and sales of
opioid drugs in the country
Global Opioids Market:
Competitive Landscape
Major players operating in the
global opioids market include Pfizer, Inc., Boehringer Ingelheim, Janssen
Pharmaceuticals, Inc., Actavis Plc., Sanofi SA, Sun Pharmaceutical Industries
Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc., and Zyla Life
Sciences.
Global Opioids Market: Key
Developments
In October 2019,
AmerisourceBergen, Cardinal Health, McKesson Corporation, Johnson &
Johnson, and Teva Pharmaceuticals agreed to pay US$ 50 billion in cash and
addiction treatments to resolve opioid cases in U.S. states. In March 2019,
Purdue Pharma reached a US$ 270 million settlement in a lawsuit, which claimed
its opioids contributed to the deaths of thousands of people.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1017
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment